Objective: The aim of this study was (1) to compare the prevalence and severity of Systemic Vasculitis (SV) in various organs of Rheumatoid Arthritis (RA) and of progressive Systemic Sclerosis (SSc) patients, (2) To determine the complications and lethal outcome caused by vasculitis in RA and SSc.
Introduction
In autoimmune diseases the vascular system is the most important target of immunological processes, manifesting as vasculitis or characteristic structural changes of blood vessels.
Systemic vasculitis of autoimmune origin (SV) may be regarded as one of the basic manifestations of rheumatoid arthritis (RA) as well [1] . As Bywaters put it, "Vasculitis is RA itself [2] ". The vasculitis and vascular changes are so dominant in progressive systemic sclerosis (SSc) that the disease could be regarded as primary vascular disease. According to Gardner "Evidence of circulatory impairment in systemic sclerosis is so frequent that is natural to ask whether this is fundamentally not a vascular disorder" [3] . This view is also supported by others [4, 5] .
The aim of this study was [1] to compare the prevalence and severity of SV in various organs of RA and SSc patients, [2] to determine the complications and lethal outcome caused by vasculitis in RA and SSc.
Patients and Methods
At the National Institute of Rheumatology 9475 patients died between 1969 and 1992; among them 161 with RA and all of them were autopsied. RA and SSc were confirmed clinically according to the criteria of the American College of Rheumatology (ACR) [6, 7] .
The basic disease, the complications, and the lethal outcome caused by vasculitis were determined and analyzed retrospectively, reviewing the clinical and pathological reports, tissue samples, and the histological slides.
The existence (prevalence) and severity of vasculitis in various organs was determined histologically.
Glossary of Definitions
"Prevalence" means the presence of vasculitis in different organs.
"Prevalence" of vasculitis indicates the presence of vasculitis in blood vessels of different calibers in various organs.
"Severity" indicates different degrees of inflammation (density of inflamed sections) of blood vessels in various organs.
"Severity" of vasculitis was evaluated by semi-quantitative, visual estimation on a 0 to 3 plus scale (based on the number of involved vessels/light microscopic field x40 by Olympus BX51).
Semi-Objective Score System of "Severity" "0" -no vasculitis "1" -occasional blood vessels with vasculitis "2" -less than 5 involved blood vessels per microscopic field with an x20 objective. (In case of medium size arteries or veins it corresponds to the absolute number of involved medium size vessels of a tissue sample, e.g. less than five medium size vessels/ tissue sample) "3" -Five or more involved blood vessels/microscopic field with a x20 objective (In case of medium size arteries or veins this corresponds to the absolute number of involved medium size vessels of tissue sample, e.g. 5 or more than five medium size vessels/tissue sample)
The average value of vasculitis / patients was calculated by visually evaluating the histologic specimens (on a 0 to 3 plus scale) and the sum divided by the number of available specimens. The results have been tabulated in the horizontal lines. This technique was used to evaluate each organ and the results are represented in the vertical columns.
Vasculitis was defined as non-specific, fibrinoid necrotic and/ or granulomatous types of vasculitis in RA, and as non-specific or fibrinoid necrotic vasculitis with or without fibromuscular and/ or intimal proliferation and successive adventitial fibrosis (FIP) in SSc [8] .
The correlations were calculated by Student (Welch) t-probe, comparing the severity of vasculitis in RA and SSc patients.
The links between severity, mortality, and clinical diagnosis of vasculitis were determined by χ²-test.
Results
Existence (prevalence) and severity of SV in various organs of 33 RA patients
The existence (prevalence) and severity of vasculitis in 12 organs (heart, lung, liver, spleen, kidney, pancreas, gastrointestinal tract, adrenal gland, skeletal muscle, peripheral nerve, skin and brain) of 33 RA patients with SV of autoimmune origin is summarized in table 1 and illustrated in figure 1a and Figure 1b . Severe SV had a direct causal role in the death in 4 of 8, and mild SV in 15 of 25 cases. There was no significant correlation between the severity of SV and mortality (χ²=0.2481, p<0.61).
Severe vasculitis was clinically recognized in 2 of 8, and mild in 4 of 25 cases. There was no significant correlation between the clinical diagnosis of SV and severity (χ²=0. 33, p<0.56 1…  4…  1…  4…  9…  8…  1…  1…  2…  4…  1…  6…  2…  2…  2…  2…  2…  3…  2…  8…  3…  1…  2…  2…  V…  2…  2…  1…  3…  1…  1… In RA the heart, skeletal muscle, lung, pancreas, kidneys and gastrointestinal tract were the most markedly involved organs by SV (Figure 1b) .
Existence (prevalence) and severity of SV in various organs of 11 SSc patients
The existence (prevalence) and severity of vasculitis in 12 organs (heart, lung, liver, spleen, kidney, pancreas, gastrointestinal tract, adrenal gland, skeletal muscle, peripheral nerve, skin and brain) of 11 SSc patients with SV is summarized in table 2 and illustrated in figure 3a SV revealed significantly higher values of severity in SSc patients (p < 0.00003), than in RA patients. The values of severity were also significantly higher in all organs of SSc patients than in RA patients.
SV with or without fibro muscular and/or intimal proliferation and consecutive interstitial fibrosis led to death in all (100%) 11 SSc patients. Six patients died of uremia (due to complex nephropathy) and 5 patients died of circulatory failure (due to endo-myocardial fibrosis or myocardiocytolysis -with or without honeycomb lung).
The cause of death was clinically recognized in all (100%) cases, but vasculitis expressis verbis was mentioned only in 2 of 11 SSc patients.
Vasculitis was present in all organs (100%) 11 SSc patients.
Seven patients (63.63%) had severe (with an average cumulative value of severity/SSc patient with SV >1.0), and 4 (36.36%) had mild SV (with an average cumulative value of severity/SSc patient with SV <1.0) Two patients (18.18%) of 11 had extremely severe SV (with an average cumulative value of severity/SSc patient with SV >1.75), and 9 (81.82%) of 11 had a mild or moderate degree of SV (with an average cumulative value of severity/SSc patient with SV <1.0).
The severity of SV did not influence the lethal outcome due to uremia (association's coefficient =-0.6, χ²=0.1604, p<0.68) or heart failure (association's coefficient =0.6, χ²=0.1604, p<0.61).
Vasculitis ("expressis verbis") was mentioned only in 2 of 11 SSc patients. In both cases the SV was severe. There was no significant correlation between the clinical diagnosis of SV and severity (χ²=0.1364, p<0.71).
The severity of vasculitis in SSc patients showed a step-wise ascending growth according to increasing average values of vasculitis/patient. There was no gradual transition between the "extremely severe" and "mild or moderate degree" of SV ( Figure  2 and Figure 3a) .
In SSc the kidneys, spleen, lung, pancreas, heart and gastrointestinal tract were the most markedly involved organs by SV (Figure 3b ).
The average value of severity/patients in SSc was appreciably higher than that of RA. The severity of vasculitis in both groups of patients showed a step-wise ascending curve according to the 
Discussion Prevalence and nature of SV in RA
The pertinent literature [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] about the prevalence of systemic vasculitis in RA is summarized in table 3. Most of these earlier studies based on the evaluation of some organs, discuss the prevalence of SV in RA patients only and did not specify the role of vasculitis as a factor in mortality.
Beside our earlier publications [21, 22, 23] , according to our best knowledge, a detailed analysis of SV regarding the prevalence and severity in various organs has not been available in the literature. Because of the diminishing numbers of autopsies such extensive studies are unlikely to be available in the future.
In RA patients not all examined organs were involved by SV, and prevalence and severity of vasculitis in each organ was different (Table 1 ).
In RA the heart, skeletal muscles, lung, pancreas, kidneys and gastrointestinal tract were most markedly involved, representing the main targets of autoimmune processes in RA (Figure 1a ).
In our patients there was no correlation between the severity or mortality and clinical diagnosis of SV. The mortality due to SV depends on the location of the affected vessels (and involved organs), and not by the severity of SV. For example, mild SV involving the brain may be lethal; on the other hand, severe vasculitis of the skin may not be life-threatening. The clinical diagnosis of vasculitis was established mostly by visible skin involvement.
Prevalence and nature of SV in SSc
It is generally accepted, that SV has a basic role in organ involvement of SSc. There are excellent descriptions about the morphology of vasculitis and vascular changes in SSc [24] [25] [26] [27] , but these do not mention the prevalence in percent, neither in various organs, nor in mortality. Most of the autopsy studies focus on organ involvement only [26, 27, 28] .
In SSc patients SV was present in each of the examined organs, with different degrees of severity (Table 2) .
SV was most dominant in the kidneys, spleen, lung, pancreas, heart and gastrointestinal tract of SSc patients in comparison with the involvement of the skin (Figure 3b ).
The high prevalence of vasculitis in the kidneys (with complex nephropathy), in the heart (with consecutive endo-myocardial fibrosis or myocardiocytolysis), in the lungs (with interstitial, and "honeycomb" fibrosis), and in the gastrointestinal tract (with consecutive submucosal fibrosis) [26] [27] [28] correlate with the characteristic cardiac, pulmonary, renal and gastrointestinal clinical signs of SSc patients, and remind us to carefully evaluate the symptoms of these [29] [30] [31] . The SSc patients died of uremia caused by complex nephropathy, or heart failure due to endo-myocardial fibrosis or myocardio cytolysis with or without honeycomb lung. The severity of SV did not influence the lethal outcome due to uremia or heart failure. Less severe but relapsing vasculitis with consecutive fibrosis may lead to death in these organs by uremia or heart failure. The clinical diagnosis in our patients was based on the Raynaud's phenomenon or skin involvement not influenced by the severity of SV.
In RA or SSc the most markedly involved organs denote a favorable site for histological diagnosis of SV, for example skeletal muscle with peripheral nerve (sural nerve) or G-I tract in RA and the G-I tract in SSc prior to the more visible skin involvement.
The high prevalence of SV in the pancreas may cause multifocal (microfocal recurrent) acute pancreatitis without lethal outcome in both diseases. The multifocal pancreatitis and multifocal fibrosis due to vasculitis is a newly recognized entity in RA [1, 32] and in SSc [33] , not mentioned in earlier comprehensive descriptions of pathological changes [26] [27] [28] [29] [30] [31] .
The "average severity" of vasculitis showed a step-wise profile of intensity in both cohorts of patients. This step-wise change, without gradual transition, may indicate that different genetic, immunologic etc. factors may play a role in determining the severity of vasculitis. Conceivably, the pathogenesis of mild and extremely severe vasculitis may be different.
